BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Sarcomas AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
57 results:

  • 1. Clinical presentation of childhood soft tissue sarcomas: a systematic review and meta-analysis.
    Ni Cheallaigh L; Liu JF; Fern L; Winyard P; Walker D; Ball-Gamble A; Shanmugavadivel D
    Arch Dis Child; 2024 Jan; 109(2):113-120. PubMed ID: 37857451
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Network pharmacology and molecular docking to explore the mechanism of Sheng Xue Bao mixture against iron deficiency anemia.
    Wang Y; Qinqin H; Wang H; Zhang H; Zhang X; Liu W; Xiang Z; Gu Y
    Medicine (Baltimore); 2023 Sep; 102(37):e35012. PubMed ID: 37713882
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Prevalence and clinical implications of germline pathogenic variants in cancer predisposing genes in young patients across sarcoma subtypes.
    Carvalho NA; Santiago KM; Maia JML; Costa FD; Formiga MN; Soares DCQ; Paixão D; Mello CAL; Costa CMLD; Rocha JCCD; Rivera B; Carraro DM; Torrezan GT
    J Med Genet; 2023 Dec; 61(1):61-68. PubMed ID: 37536918
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Extracutaneous Kaposi sarcoma risk remains higher in people with HIV in the post-ART era.
    Dinh S; Malmström S; Möller IK; Yilmaz A; Svedhem V; Carlander C
    AIDS; 2023 Nov; 37(13):2041-2048. PubMed ID: 37451428
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high-volume cancer center.
    Bertuzzi AF; Grimaudo MS; Laffi A; Giordano L; Gennaro N; Cariboni U; Siracusano LV; Quagliuolo V; Colombo P; Federico D; Renne SL; Specchia C; Cananzi F; Marrari A; Navarria P; Daolio PA; Bastoni S; Santoro A
    Cancer Med; 2023 Aug; 12(15):16254-16263. PubMed ID: 37366268
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Pharmacogenomic Profiling of Cisplatin-Resistant and -Sensitive Human Osteosarcoma Cell Lines by Multimodal Targeted Next Generation Sequencing.
    Hattinger CM; Casotti C; Patrizio MP; Luppi S; Fantoni L; Scotlandi K; Ibrahim T; Serra M
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233089
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deviation from delivery of radiation therapy to childhood cancer patients: A retrospective audit.
    Agrawal R; Goel V; Anand A; Arora RS
    Pediatr Blood Cancer; 2022 Feb; 69(2):e29462. PubMed ID: 34842336
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Association of ERCC gene polymorphism with osteosarcoma risk.
    Wang G; Li J; Xu X; Gupta RK; Gao X
    Afr Health Sci; 2020 Dec; 20(4):1840-1848. PubMed ID: 34394247
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pembrolizumab as a monotherapy or in combination with platinum-based chemotherapy in advanced non-small cell lung cancer with PD-L1 tumor proportion score (TPS) ≥50%: real-world data.
    Dudnik E; Moskovitz M; Rottenberg Y; Lobachov A; Mandelboim R; Shochat T; Urban D; Wollner M; Nechushtan H; Rotem O; Zer A; Daher S; Bar J;
    Oncoimmunology; 2021 Jan; 10(1):1865653. PubMed ID: 33552685
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Pathogenic Germline Mutations in DNA Repair Genes in Combination With Cancer Treatment Exposures and Risk of Subsequent Neoplasms Among Long-Term Survivors of Childhood Cancer.
    Qin N; Wang Z; Liu Q; Song N; Wilson CL; Ehrhardt MJ; Shelton K; Easton J; Mulder H; Kennetz D; Edmonson MN; Rusch MC; Downing JR; Hudson MM; Nichols KE; Zhang J; Robison LL; Yasui Y
    J Clin Oncol; 2020 Aug; 38(24):2728-2740. PubMed ID: 32496904
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. An Age Stratified Analysis of the Access to Care Continuum Across Three Tumor Groups: Are There Delays for AYA?
    Pettit T; Sue L; Waugh V; Ballantine K; Gardner K; Bremer L; Pemberton L; Allison L; Adams S; Chou E; Spearing R
    J Adolesc Young Adult Oncol; 2019 Aug; 8(4):402-409. PubMed ID: 30912693
    [No Abstract]    [Full Text] [Related]  

  • 12. Genetic polymorphisms of ERCC-1 and ERCC-2 are not prognostic markers in osteosarcoma patients with chemotherapy: A meta-analysis in Chinese population.
    Liu D; Liu X
    Medicine (Baltimore); 2018 Dec; 97(49):e13358. PubMed ID: 30544402
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ERCC polymorphisms and risk of osteosarcoma: a meta-analysis.
    Chen XJ; Tong ZC; Kang X; Wang ZC; Huang GL; Yang TM; Dong L
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6658-6666. PubMed ID: 30402838
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The effect of ERCC1 and ercc2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients.
    Obiedat H; Alrabadi N; Sultan E; Al Shatti M; Zihlif M
    BMC Med Genet; 2018 Jul; 19(1):112. PubMed ID: 29980176
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.
    Tseng WW; Tsao-Wei DD; Callegaro D; Grignani G; D'Ambrosio L; Bonvalot S; Ethun CG; Cardona K; Mullen JT; Canter RJ; Mullinax JE; Gonzalez RJ; van Coevorden F; Albertsmeier M; Dhanireddy KK; Renne SL; Gronchi A;
    Eur J Surg Oncol; 2018 Jun; 44(6):810-815. PubMed ID: 29452860
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. First-line panitumumab plus FOLFOX4 or FOLFIRI in colorectal cancer with multiple or unresectable liver metastases: A randomised, phase II trial (PLANET-ttd).
    Carrato A; Abad A; Massuti B; Grávalos C; Escudero P; Longo-Muñoz F; Manzano JL; Gómez A; Safont MJ; Gallego J; García-Paredes B; Pericay C; Dueñas R; Rivera F; Losa F; Valladares-Ayerbes M; González E; Aranda E;
    Eur J Cancer; 2017 Aug; 81():191-202. PubMed ID: 28633089
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Haplotype analysis on relationship of ercc2 and ERCC3 gene polymorphisms with osteosarcoma risk in Chinese young population.
    Xu Q; Zhang Z; Sun W; Hu B
    Mamm Genome; 2017 Jun; 28(5-6):227-233. PubMed ID: 28474168
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Genetic polymorphisms in ERCC1 and ercc2 genes are associated with response to chemotherapy in osteosarcoma patients among Chinese population: a meta-analysis.
    Zhang H; Ge J; Hong H; Bi L; Sun Z
    World J Surg Oncol; 2017 Apr; 15(1):75. PubMed ID: 28388903
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. VIP (etoposide, ifosfamide, and cisplatin) in patients with previously treated soft tissue sarcoma.
    Moon JY; Baek SW; Ryu H; Choi YS; Song IC; Yun HJ; Jo DY; Kim S; Lee HJ
    Medicine (Baltimore); 2017 Jan; 96(4):e5942. PubMed ID: 28121937
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Thinking out of the
    Koh FH; Chan HL; Petersson F; Chong CS
    Gut; 2017 Dec; 66(12):2068-2159. PubMed ID: 27965282
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.